Allan Mark Watson
Directeur/Membre du Conseil chez Kyowa Kirin International Plc
Profil
Allan Mark Watson is currently a Director at Kyowa Kirin International Plc, Archimedes Pharma Ltd., Kyowa Kirin Pharmaceutical Development Ltd., Kyowa Kirin Ltd., Kyowa Kirin Services Ltd., Stirling Anglian Pharmaceuticals Ltd., and Kelso Pharma Ltd.
He previously served as a Director at Archimedes Pharma UK Ltd.
from 2014 to 2020.
Prior to that, he was the Co-Managing Director at Kyowa Kirin GmbH.
Mr. Watson also worked as the Chief Financial Officer at Optos Plc from 2003 to 2009.
He obtained his undergraduate degree from The Robert Gordon University.
Postes actifs de Allan Mark Watson
| Sociétés | Poste | Début |
|---|---|---|
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Directeur/Membre du Conseil | 09/09/2009 |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 05/08/2014 |
Kyowa Kirin Ltd.
 Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Directeur/Membre du Conseil | 09/09/2009 |
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 09/09/2009 |
Kyowa Kirin Services Ltd.
 Kyowa Kirin Services Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1989, Kyowa Kirin Services Ltd. is a subsidiary of Kirin Holdings Co., Ltd. that researches and develops drugs. The company is based in London, UK. | Directeur/Membre du Conseil | 05/08/2014 |
Kelso Pharma Ltd.
 Kelso Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kelso Pharma Ltd. manufactures pharmaceuticals. The company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 2020. The CEO is Harry Thomas Stratford. | Directeur/Membre du Conseil | 06/01/2021 |
Stirling Anglian Pharmaceuticals Ltd.
 Stirling Anglian Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Kelso Pharma Ltd., Stirling Anglian Pharmaceuticals Ltd. was founded in 2013 and is a medicines optimization company based in Glasgow, UK. The British company is committed to medicines optimization and has sourced and developed a portfolio of medicines to help the NHS curb waste across a range of conditions that currently place unnecessary and avoidable strain on the healthcare system. Stirling Anglian Pharmaceuticals was acquired by Kelso Pharma Ltd. on January 12, 2022. | Directeur/Membre du Conseil | 21/12/2021 |
Anciens postes connus de Allan Mark Watson
| Sociétés | Poste | Fin |
|---|---|---|
Archimedes Pharma UK Ltd.
 Archimedes Pharma UK Ltd. Medical/Nursing ServicesHealth Services Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 22/04/2020 |
| OPTOS PLC | Directeur Financier/CFO | 31/08/2009 |
| ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Allan Mark Watson
| The Robert Gordon University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Optos Plc
 Optos Plc Medical SpecialtiesHealth Technology Optos Plc manufactures and markets retinal imaging devices. Its products include ultra-widefield imaging, visual acuity, perimetry, and laser treatment products. The company was founded by Douglas Crombie Anderson in 1992 and is headquartered in Dunfermline, the United Kingdom. | Health Technology |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
Archimedes Pharma Ltd.
Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Archimedes Pharma UK Ltd.
Archimedes Pharma UK Ltd. Medical/Nursing ServicesHealth Services Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom. | Health Services |
Kyowa Kirin GmbH
 Kyowa Kirin GmbH Pharmaceuticals: MajorHealth Technology Part of Kirin Holdings Co., Ltd., Kyowa Kirin GmbH is a German company that manufactures and supplies pharmaceutical products. The company is based in Dusseldorf, Germany. The company was founded in 2011. The CEO is Norberto Villarrasa Justicia. | Health Technology |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Health Technology |
Kyowa Kirin Pharmaceutical Development Ltd.
Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
Kyowa Kirin Services Ltd.
Kyowa Kirin Services Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1989, Kyowa Kirin Services Ltd. is a subsidiary of Kirin Holdings Co., Ltd. that researches and develops drugs. The company is based in London, UK. | Commercial Services |
Kelso Pharma Ltd.
Kelso Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kelso Pharma Ltd. manufactures pharmaceuticals. The company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 2020. The CEO is Harry Thomas Stratford. | Health Technology |
Stirling Anglian Pharmaceuticals Ltd.
Stirling Anglian Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Kelso Pharma Ltd., Stirling Anglian Pharmaceuticals Ltd. was founded in 2013 and is a medicines optimization company based in Glasgow, UK. The British company is committed to medicines optimization and has sourced and developed a portfolio of medicines to help the NHS curb waste across a range of conditions that currently place unnecessary and avoidable strain on the healthcare system. Stirling Anglian Pharmaceuticals was acquired by Kelso Pharma Ltd. on January 12, 2022. | Health Technology |